The efficacy of oral and subcutaneous antigen-specific immunotherapy in murine cow’s milk- and peanut allergy models
Abstract Background Antigen-specific immunotherapy (AIT) is a promising therapeutic approach for both cow’s milk allergy (CMA) and peanut allergy (PNA), but needs optimization in terms of efficacy and safety. Aim Compare oral immunotherapy (OIT) and subcutaneous immunotherapy (SCIT) in murine models...
Main Authors: | Marlotte M. Vonk, Laura Wagenaar, Raymond H. H. Pieters, Leon M. J. Knippels, Linette E. M. Willemsen, Joost J. Smit, Betty C. A. M. van Esch, Johan Garssen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-09-01
|
Series: | Clinical and Translational Allergy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13601-017-0170-y |
Similar Items
-
Non-digestible oligosaccharides scFOS/lcFOS facilitate safe subcutaneous immunotherapy for peanut allergy
by: Laura Wagenaar, et al.
Published: (2019-04-01) -
Improved Efficacy of Oral Immunotherapy Using Non-Digestible Oligosaccharides in a Murine Cow’s Milk Allergy Model: A Potential Role for Foxp3+ Regulatory T Cells
by: Marlotte M. Vonk, et al.
Published: (2017-09-01) -
Adjuvanted Immunotherapy Approaches for Peanut Allergy
by: Brandi T. Johnson-Weaver, et al.
Published: (2018-09-01) -
Peanut Allergy: An Overview
by: Al-Ahmed Nasser, et al.
Published: (2008-12-01) -
First reported case in Canada of anaphylaxis to lupine in a child with peanut allergy
by: Lianne Soller, et al.
Published: (2018-10-01)